Candel Therapeutics, Inc. (CADL)
6.20
-2.19
(-26.10%)
USD |
NASDAQ |
Nov 13, 16:00
6.05
-0.15
(-2.42%)
After-Hours: 19:59
Candel Therapeutics Total Assets (Quarterly) : 211.11M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 211.11M |
| June 30, 2026 | 208.15M |
| March 31, 2026 | 201.92M |
| December 31, 2025 | 125.63M |
| September 30, 2025 | 93.60M |
| June 30, 2025 | 105.97M |
| March 31, 2025 | 95.90M |
| December 31, 2024 | 107.14M |
| September 30, 2024 | 21.52M |
| June 30, 2024 | 26.48M |
| March 31, 2024 | 31.22M |
| December 31, 2023 | 41.70M |
| Date | Value |
|---|---|
| September 30, 2023 | 50.06M |
| June 30, 2023 | 58.71M |
| March 31, 2023 | 67.24M |
| December 31, 2022 | 78.52M |
| September 30, 2022 | 85.01M |
| June 30, 2022 | 93.30M |
| March 31, 2022 | 101.56M |
| December 31, 2021 | 89.20M |
| September 30, 2021 | 95.96M |
| June 30, 2021 | 30.74M |
| March 31, 2021 | 35.09M |
| December 31, 2020 | 38.28M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oragenics, Inc. | 3.282M |
| Arcturus Therapeutics Holdings, Inc. | 215.32M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 79.52M |
| Shareholders Equity (Quarterly) | 131.59M |
| Debt to Equity Ratio | 0.3782 |
| Current Ratio | 7.571 |
| Net Debt Paydown Yield | -1.01% |